Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis

Background: Sodium–glucose co-transporter 2 (SGLT2) inhibitors are an emerging class of glucose-lowering drugs that have become increasingly relevant for the treatment and prevention of heart failure (HF). Therefore, we aimed to investigate various SGLT2 inhibitors in patients with established HF at...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cardiovasc Med
Main Authors: Gager, Gloria M., Gelbenegger, Georg, Jilma, Bernd, von Lewinski, Dirk, Sourij, Harald, Eyileten, Ceren, Filipiak, Krzysztof, Postula, Marek, Siller-Matula, Jolanta M.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Cardiovascular Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316592/
https://ncbi.nlm.nih.gov/pubmed/34336954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.691907
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados